Correspondence.

SSRIs

Your article on the controversy surrounding selective serotonin reuptake inhibitors (SSRIs) (1) is very much appreciated by many people.

SSRI Stories now contains 628 murder incidents, counting school shootings and workplace violence, and more than 200 murder-suicides. Even if the violence cannot be proven to result from the antidepressant, there is at least evidence that in these particular cases, the SSRI did not make the perpetrators calmer, more relaxed, or happier people.

Dr. Kauffman's article was thorough and scientific. The bibliography was impressive. Thank you for publishing it.

Rosie Meysenburg

Moderator: www.SSRIstories.com

I want to applaud the Journal for having the courage to publish the article on SSRI drugs. Dr. Kauffinan did an excellent job of detailing the facts. (1)

Having spent approximately two decades gathering information on SSRI-related problems so that journalists would be encouraged to ask the right questions, it is gratifying to see a medical journal finally address this issue.

Physicians need to be aware of the serious adverse reactions associated with SSRI use. Dr. Kauffman's article will serve to heighten this awareness to the benefit of patients everywhere.

Ann Blake Tracy, Ph.D.

Executive Director, International Coalition for Drug Awareness

(1) Kauffman JM. Selective serotonin reuptake inhibitor (SSRI) drugs: more risks than benefits? J Am Phys Surg 2009; 14:7-12.